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SUPPLEMENTARY NOTES
ABSTRACT
Rho-family GTPases are the major regulators of the actin and microtubule cytoskeleton. Regulators of the GTPases include GEFs and GAPs, which control activation and deactivation, respectively, of this family of molecular switches. This study explores the role of the GEF Tiam2 in breast cancer cell proliferation and invasion, which was initially discovered using a siRNA screen in MDA-MB-231 breast cancer cells. Protein expression studies are performed using a panel of cell lines, revealing that Tiam2 expression is upregulated in Ras mutant cells. Additionally, Tiam2 depletion causes MDA-MB-231 cells to form fewer colonies in soft agar colony formation assays. Work continues on this project to determine how Tiam2 contributes to breast cancer proliferation and invasion using both cell culture and mouse models.
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Introduction
Rho family GTPases, members of the Ras superfamily, are best known for their regulation of the actin and microtubule cytoskeleton. [1] Misregulation of Rho signaling pathways can contribute to oncogenesis through effects on cell proliferation, adhesion, and migration. [2] There is evidence that mutations or alterations in expression levels of the Rho GTPase regulatory proteins, guanine nucleotide exchange factors (GEFs) and activating proteins showed that Tiam2 probes on the microarray chips were unable to specifically detect changes in Tiam2 levels (data not shown).
To rescue the invasion defect caused by siRNA depletion of Tiam2, a full-length human The two hairpins used to successfully stably deplete Tiam2 in MDA-MB-231 colony formation assays were selected for use in a mouse tumorigenesis assay. Work has just begun in collaboration with the lab of Dr. Jacqueline Bromberg, to inject into NOD/SCID mice determine how Tiam2 affects tumor growth in vivo. Derivative cell lines will be isolated from these mice so that further in vitro characterization of signaling pathways affecting growth and invasion can be later explored more thoroughly. Specifically, the level of GTPase activation will be studied along with other possible effector molecular targets [9] .
Key Research Accomplishments
• Tiam2 expression is up-regulated in Ras mutant cancer cell lines.
• Tiam2 depletion inhibits the formation and growth of colonies in soft agar.
• Creation of MDA-MB-231 lines stably expressing siRNA-resistant Tiam2.
• Creation of MDA-MB-231 lines stably expressing shRNA depleting Tiam2 levels.
Reportable Outcomes
• 
Conclusion
This study illustrates the importance of careful analysis of expression levels independent of microarray data. Increased expression of Tiam2 protein and mRNA in Ras-mutant breast cancer cell lines is unexpected and overlooked by previous work. Further studies should explore the link between these expression patterns as well as transcriptional regulation of protein expression during metastasis. Invasion studies, while slowed by the inability of Tiam2 overexpression to rescue invasion inhibition, still imply that Tiam2 could play a role in cell motility. Further work using animal models is currently underway to further elucidate the importance of Tiam2 in tumor formation, progression, and metastasis. This work will add insight into the molecular mechanisms by which cancer cells invade into surrounding tissue and eventually result in death.
